NEOMED

The July/August 2016 of The Research Advocate is now online . Highlights from this month include: Announcing a new interactive map and blog as part of the national voter education initiative Campaign for Cures . The user-friendly map of the U.S. features hundreds of quotes on medical progress from candidates across the political spectrum. The Campaign for Cures blog is packed with information related to the election, patient stories, events, and commentary on science, research, and innovation. Registration is now open for the 2016 National Health Research Forum . The event, titled Straight Talk: New Thinking on Tough Challenges , will feature thought-provoking panel discussions on complex...
Dear Research Advocate: This has been an important week for research, innovation and the power of advocacy. The Senate Appropriations Committee passed the Labor-H bill, which funds NIH, CDC and AHRQ, among other programs. The bill includes a well-justified, but nonetheless remarkable, $2 billion increase for NIH in FY17. However, CDC and AHRQ both receive cuts in the bill ($118 million and $10 million, respectively). While we applaud Chairman Blunt (R-MO), Ranking Member Murray (D-WA) and the Committee as a whole for their extraordinary determination to regrow the NIH budget, underinvesting in CDC and AHRQ is a costly mistake. Read our statement on the bill. It is important to note that...
Dear Research Advocate: The news from the CDC this week is concerning. For the first time in over a decade the overall, all-cause mortality rate for the U.S. is higher than in the preceding year. This unexpected news comes on the heels of last week’s announcement confirming the first U.S. case of an E. coli infection resistant to colistin, a last-resort antibiotic, reminding us of just how important it is to curtail and outpace antimicrobial resistance. And we have word of the second baby born in the U.S. with microcephaly due to Zika, as well as a new estimate that 300 pregnant women in the U.S. have the virus. On their own, each of these stories should serve as a wake-up call for...
The May/June 2016 issue of The Research Advocate is now online . Highlights from this month include: Research!America board members Bill Hait, M.D. , Janssen Research & Development, and Keith Yamamoto, Ph.D ., University of California, San Francisco, will be discussing the concept of immorbidity on June 8 at the BIO International Convention. “Medical Research: The Right Prescription for Economic Growth” will be taking place June 6 on the campus of Northeast Ohio Medical University (NEOMED) in Rootstown, Ohio. A federal policy update on the Senate Innovations initiative, the current status of appropriations for NIH, NSF and FDA, and the recent announcement of the new AHRQ director. Learn...
Why Research is Needed Now to Stop the Progression of Parkinson’s Disease Not long ago, as I approached middle age, I started feeling like I hit a wall. It didn’t make sense to me. At age 40 I set out on a path to be healthy at age 50, both physically and emotionally. I knew a lot of people who burned out at 50 and I wasn’t going to be one of them. I exercised regularly and ate a healthy diet heavy on fruits and vegetables. I had a strong support network both at home and work. Looking from the outside everything was great – our family was all healthy, our business had recovered from the great recession and everything seemed to be going my way both personally and professionally. Still,...
This article appeared in the March/April edition of Ohio Matters, the official publication of the Ohio Chamber of Commerce. As Ohio’s leading sector, the biomedical industry plays an important role in the state’s economy, and the resources to support the research being done by colleges, universities and industries to advance societal health must continue to expand. From protecting us against mosquito-borne pathogens such as the Zika virus or food-borne pathogens such as E. coli O26, Salmonella and Listeria, we constantly need new methods of detection, prevention and treatment, all of which are made possible by the research conducted by dedicated biomedical scientists, research that costs...

Sidebar Quote

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America